FDA Drug recall D-901-2013
Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories,…
- FDA Drug
- Class III
- terminated
- Published 2013-08-28
On 2013-08-28 the FDA classified a Class III recall of Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories,… by Abbvie, citing labeling: Incorrect Package Insert; product packaged with outdated version of the insert.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-901-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-08-01 |
| Published | 2013-08-28 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Abbvie |
| Distribution | US |
Product
Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA
Reason
Labeling: Incorrect Package Insert; product packaged with outdated version of the insert
Identifiers
| code_info | Lot 22033GY |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-901-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.